Citation from the publications of

Vezzani, Annamaria; Bartfai, Tamas; Bianchi, Marco; Rossetti, Carlo; French, Jacqueline
"Therapeutic potential of new antiinflammatory drugs"
Epilepsia 2011 Oct; 52 Suppl 8():67-69
Experimental and clinical findings have shown in the past decade that specific proinflammatory mediators and their cognate receptors are upregulated in epileptic brain tissue. In particular, the IL-1 receptor (R)/Toll-like receptor (TLR) signaling pathways are activated in experimental models of seizures and in human epileptic tissue from drug-resistant patients. Pharmacological targeting of these proinflammatory pathways using selective receptor antagonists, or the use of transgenic mice with perturbed cell signaling, demostrated that the activation of IL-1R type 1 and TLR4 by their respective endogenous ligands, i.e., interleukin (IL)-1b and High Mobility Group Box 1, is implicated in the precipitation and recurrence of experimentally induced seizures in rodents. This evidence highlights a new target system for pharmacological intervention to inhibit seizures by interfering with mechanisms involved in their genesis and recurrence.

Check for full text:  

# 450802 (MEDL:21967368)

This publication list a product of the NYU Faculty Bibliography.